Skip to main content
OpenTrials
Completed

NCT Number: NCT00950313

Assessment of Response Rates and Yields for Two Tools for Early Detection of Non-diabetic Hyperglycaemia and Diabetes

The purpose of this study is to establish the most effective method of increasing attendance to screening of type 2 Diabetes within a primary care setting within the backdrop of the NHS Health Check programme.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

40 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Leicester City PCT

Leicester, Leicestershire, United Kingdom

About this study

The University Hospitals of Leicester and The University of Leicester have developed a self-assessment risk score and a practice data risk score that can be used in a variety of setting to detect undiagnosed diabetes and impaired glucose regulation. This is done to establish a simple and effective 1st stage screen to identify those people at risk of diabetes and engage the public to increase the number of high risk individuals attending screening invitations but reducing the overall number of oral glucose tolerance tests. This study aims to test in a pragmatic way the use of such tools in a primary care setting administered by primary care staff as part of the NHS Health Check programme.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 40-75 years old (30 -75 years old if South Asian origin)

Exclusion criteria

  • Current diagnosis of diabetes
  • Terminal illness or mental incapacity

Treatment and study plan

Self assessment

Other

Self assessment used to determine current risk of diabetes and likelihood of requiring further testing

Electronic risk score

Other

Patients current risk of diabetes is determined by a electronic risk algorithm. They are then invited to attend fof further testing.

Primary outcomes

  1. Increase in response rates to invitation to 2nd stage blood test

    Time frame: 12 months

Secondary outcomes

  1. Increase in yield of OGTT positive results through filtering of high risk participants that pass 1st and 2nd stage screens

    Time frame: 12

Sponsors and collaborators

Lead sponsor

University of Leicester

Other

Collaborators

  • University Hospitals, Leicester

Registry information

Acronym: ATTEND

Important dates

Study start
2011
Primary completion
2014
Study completion
2014
First posted
Jul 31, 2009
Registry last updated
Jan 30, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.